← Back to Clinical Trials
Recruiting NCT06414668

NCT06414668 The ENERGYCO Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06414668
Status Recruiting
Phase
Sponsor Universidad de Granada
Condition Energy Expenditure
Study Type INTERVENTIONAL
Enrollment 300 participants
Start Date 2023-02-01
Primary Completion 2025-06-30

Trial Parameters

Condition Energy Expenditure
Sponsor Universidad de Granada
Study Type INTERVENTIONAL
Phase N/A
Enrollment 300
Sex ALL
Min Age 12 Years
Max Age 17 Years
Start Date 2023-02-01
Completion 2025-06-30
Interventions
Cycling Intervention Group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The aims of this school-based cycling intervention called "ENERGY Commuting to school" (ENERGYCO) will be divided into two phases: Phase I will aim: 1) to design, test, and validate predictive equations for the objective quantification of the energy expenditure related to different modes of commuting to school (i.e., walking, cycling, motorized-vehicle); and 2) to quantify the energy expenditure of each mode of commuting to school using indirect calorimetry in adolescents; and Phase II will aim to evaluate the effect of a school-based cycling intervention on different health-related outcomes, such as energy expenditure, resting metabolic rate, basal metabolism, physical activity levels, body composition, muscle strength, cardiorespiratory fitness, blood pressure, physical literacy, motor competence, and psychosocial outcomes on Spanish adolescents.

Eligibility Criteria

Inclusion Criteria: 1. the school has a specific space for parking bicycles and allows for their parking 2. the school does not have a specific school bus route 3. the school has at least two lines per class 4. at least eight students from the school will agree to participate in the study (i.e., presenting a signed parental consent).

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology